{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:23:01Z","timestamp":1772706181165,"version":"3.50.1"},"reference-count":47,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"Ministry of Education and Science, the Republic of Serbia,","award":["43012"],"award-info":[{"award-number":["43012"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["SAR and QSAR in Environmental Research"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.1080\/1062936x.2018.1485737","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T09:14:06Z","timestamp":1532942046000},"page":"503-515","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Development of non-peptide ACE inhibitors as novel and potent cardiovascular therapeutics: An in silico modelling approach"],"prefix":"10.1080","volume":"29","author":[{"given":"V.","family":"Stoi\u010dkov","sequence":"first","affiliation":[{"name":"Institute for Cardiovascular Rehabilitation, Faculty of Medicine, University of Nis, Niska Banja, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"\u0160ari\u0107","sequence":"additional","affiliation":[{"name":"Institute for Cardiovascular Rehabilitation, Faculty of Medicine, University of Nis, Niska Banja, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Golubovi\u0107","sequence":"additional","affiliation":[{"name":"Center for Anesthesiology and Reanimatology, Clinical Center Ni\u0161, Ni\u0161, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zlatanovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Physical Medicine and Rehabilitation, Clinical Center Ni\u0161, Ni\u0161, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Krtini\u0107","sequence":"additional","affiliation":[{"name":"Department for Pharmacology and Toxicology, Faculty of Medicine, University of Ni\u0161, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Dini\u0107","sequence":"additional","affiliation":[{"name":"Department of Urology, Clinical Center Ni\u0161, Ni\u0161, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mladenovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology and Hepatology, Clinical Center Ni\u0161, Ni\u0161, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sokolovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, University of Ni\u0161, Ni\u0161, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Veselinovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Medicine, University of Ni\u0161, Ni\u0161, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"CIT0001","first-page":"747","volume":"86","author":"Paul M.","year":"2006","journal-title":"Rev"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(02)00178-4"},{"key":"CIT0003","first-page":"77","volume":"19","author":"Pagliaro P.","year":"2005","journal-title":"Drug Ther"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(02)00309-6"},{"key":"CIT0005","unstructured":"E.K. Jackson,Renin and angiotensin, inGoodman and Gilman\u2019s the Pharmacologic Basis of Therapeutics, 10th ed. J.G. Hardman, L.E. Limberd and A.G. Gilman, eds., McGrawHill, New York, 2001, pp. 809\u2013829."},{"key":"CIT0006","volume-title":"Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase Nin human plasma, Am. J. Physiol. Heart Circ. Physiol. 278","author":"Kuoppala A.","year":"2000"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03234.x"},{"key":"CIT0008","unstructured":"J.W. Wright, S. Mizutani, and J.W. Harding,Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies, Heart Fail Rev. 13 (2008), pp. 367\u2013375."},{"key":"CIT0009","unstructured":"M. Butters,Systemic hypertension, inCurrent Medical Diagnosis and Treatment, S.J. McPhee, M.A. Papadakis and L.M. Tierney, eds. McGraw-Hill, New Jersey, 2008, pp. 371\u2013399."},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464220-00004"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1681\/ASN.V7102025","volume":"7","author":"Matsusaka T.","year":"1996","journal-title":"Am. Soc. Nephrol."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0b013e3281a7ec81"},{"key":"CIT0013","unstructured":"R. Latini, A.P. Maggioni, M. Flather, P. Sleight, and G. Tognoni,ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials, Circulation 92 (1995), pp. 3132\u20133137."},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200412000-00003"},{"key":"CIT0015","unstructured":"R.W. Nesta and S. Zarich,Acute myocardial infarction in diabetes mellitus: Lessons learned from ACE inhibition, Circulation 97 (1998), pp. 12\u201315."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-999-0017-6"},{"key":"CIT0017","unstructured":"H. Yokoyama, O. Tomonaga, M. Hirayama, A. Ishii, M. Takeda, T. Babazono, U. Ujihara, C. Takahashi, and Y.Omori,Predictors of the progression of diabetic 0 nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients, Diabetologia 40 (1997), pp. 405\u2013411."},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.2174\/138161207782794257"},{"key":"CIT0019","unstructured":"J. Verma, V.M. Khedkar, and E.C. Coutinho,3D-QSAR in drug design \u2013 A review, Curr, Top, Med, Chem, 10 (2010), pp. 95\u2013115."},{"key":"CIT0020","unstructured":"A.Z. Dudek, T\u0301. Arodz, and J. G\u00e1lvez,Computational methods in developing quantitative structure-activity relationships (QSAR): A review, Comb. Chem. High. T. Scr. 9 (2006), pp. 213\u2013228."},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1021\/ci100176x"},{"key":"CIT0022","unstructured":"C. Nantasenamat, C. Isarankura-Na-Ayudhya, T. Naenna, and V. Prachayasittikul,A practical overview of quantitative structure-activity relationship, EXCLI J. 8 (2009), pp. 74\u201388."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.2174\/156802608786786552"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.3390\/ijms10051978"},{"key":"CIT0025","unstructured":"H. Kubinyi,QSAR and 3D QSAR in drug design part 2: Applications and problems, Drug Discov. Today2 (1997), pp. 538\u2013546."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.2174\/1568005024605909"},{"key":"CIT0027","unstructured":"A.U. Khan,Descriptors and their selection methods in QSAR analysis: Paradigm for drug design, Drug Discov Today 21 (2016), pp. 1291\u20131302."},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150506151533"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.03.075"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-014-3977-2"},{"key":"CIT0031","unstructured":"A. Kumar and S. Chauhan,Monte Carlo method based QSAR modelling of natural lipase inhibitors using hybrid optimal descriptors, SAR QSAR Environ Res 28 (2017), pp. 179\u2013197."},{"key":"CIT0032","unstructured":"V. Prachayasittikul, A. Worachartcheewan, A.P. Toropova, A.A. Toropov, N. Schaduangrat, V. Prachayasittikul, and C. Nantasenamat,Large-scale classification of P-glycoprotein inhibitors using SMILE S-based descriptors, SAR QSAR Environ Res 28 (2017), pp. 1\u201316."},{"key":"CIT0033","unstructured":"J.B. Veselinovi\u0107, G.M. Nikoli\u0107, N.V. Truti\u0107, J.V. \u017divkovi\u0107, and A.M. Veselinovi\u0107,Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase, SAR QSAR Environ Res. 26 (2015), pp. 449\u2013460."},{"key":"CIT0034","unstructured":"D.B. Kitchen, H. Decornez, J.R. Furr, and J. Bajorath,Docking and scoring in virtual screening for drug discovery: Methods and applications, Nat. Rev. Drug Discov. 3 (2004), pp. 935\u2013949."},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1002\/prot.10115"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2015.02.011"},{"key":"CIT0037","first-page":"57","volume":"28","author":"Suh J.T.","year":"1985","journal-title":"New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives, J. Med. Chem"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.3923\/ajdd.2011.85.104"},{"key":"CIT0039","first-page":"1369","volume":"24","author":"Toropov A.A.","year":"2013","journal-title":"Chem"},{"key":"CIT0040","first-page":"33","volume":"29","author":"Toropov A.A.","year":"2017","journal-title":"Chem"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2017.01.198"},{"key":"CIT0042","first-page":"441","volume":"29","author":"Stoi\u010dkov V.","year":"2018","journal-title":"Chem"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1021\/jm051197e"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1021\/ci200227u"},{"key":"CIT0045","unstructured":"K. Roy, R.N. Das, P. Ambure, and R.B. Aher,Be aware of error measures. Further studies on validation of predictive QSAR models, Chemom. Intell. Lab. Syst. 152 (2016), pp.18\u201333."},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2017.1288659"},{"key":"CIT0047","first-page":"973","volume":"28","author":"Bhargava S.","year":"2017","journal-title":"Res"}],"container-title":["SAR and QSAR in Environmental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1062936X.2018.1485737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T11:47:20Z","timestamp":1661687240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1062936X.2018.1485737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,3]]}},"alternative-id":["10.1080\/1062936X.2018.1485737"],"URL":"https:\/\/doi.org\/10.1080\/1062936x.2018.1485737","relation":{},"ISSN":["1062-936X","1029-046X"],"issn-type":[{"value":"1062-936X","type":"print"},{"value":"1029-046X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=gsar20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=gsar20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}